THANZ Multidisciplinary VITT Guideline for Doctors

Posted: 25th of May, 2021

A severe prothrombotic syndrome associated with thrombocytopenia has been described in a small number of patients exposed to the COVID-19 AstraZeneca and Janssen (Johnson & Johnson) vaccine. This syndrome is currently being called several names: VITT (vaccine-induced immune thrombotic thrombocytopenia), TTS (thrombosis with thrombocytopenia syndrome), and VIPIT (vaccine-induced prothrombotic immune thrombocytopenia).

For the purposes of this Thrombosis & Haemostasis Society of Australia New Zealand (THANZ) Multidisciplinary Guideline, the term VITT will be used. Please click here to download the guideline.